CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive grade 1 or grade 2 GEP-NETs.

After a second breast cancer diagnosis at 61, I faced 17 rounds of chemo, surgery and radiation, changing my perspective on life and leading to a new normal.

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...